by EmpathiCSubstanceS | Jun 11, 2019 | Anxiety
IN AN AIRY Denver café populated almost entirely by young people staring at laptops, Travis Tyler Fluck—dressed in an orange velour jacket, over which is draped a thin braided lock of hair—takes out his phone and pulls up Craigslist. A quick search lands him on a post...
by EmpathiCSubstanceS | Jun 5, 2019 | Alcoholism
The Oakland City Council passed a resolution Tuesday night that decriminalizes certain natural psychedelics, including mushrooms, a move that makes Oakland the second city in the nation to do so. The resolution instructs law enforcement to stop investigating and...
by EmpathiCSubstanceS | May 23, 2019 | Alcoholism
A newly published study examining the use of psychedelics in non-clinical settings to treat alcoholism is suggesting a great number of individuals see a reduction in problematic alcohol consumption following strong doses of LSD or psilocybin. The research supplements...
by EmpathiCSubstanceS | Mar 19, 2019 | Depression
A new survey into the anti-depressant qualities of a short-acting psychedelic has reported extraordinarily positive improvements in well-being. The research, led by a team from Johns Hopkins University, suggests the brief duration of action seen in the drug 5-MeO-DMT...
by EmpathiCSubstanceS | Feb 13, 2019 | Depression
A new nasal spray for depression, utilizing a novel drug called esketamine, has passed the last step on its way to final FDA approval. An advisory panel to the Food and Drug Administration (FDA) voted in favor of the new drug’s risk/benefit profile meaning the...
